AbbVie Inc. (ABBV) Stock Forecast & Price Prediction 2025, 2030, 2040, and 2050
Get detailed AbbVie Inc. (ABBV) stock forecast for 2025, monthly, along with long-term ABBV price prediction from 2025 to 2050. Look at historical stock performance, analyst recommendations (Buy, Sell, or Hold), and the latest AbbVie Inc. headlines.
1 Month Prediction
$363.75 [72.60%]
3 Month Prediction
$382.07 [81.29%]
6 Month Prediction
$422.73 [100.58%]
1 Year Prediction
$468.33 [122.22%]
3 Year Prediction
$640.58 [203.95%]
5 Year Prediction
$813.40 [285.95%]
About AbbVie Inc.
AbbVie Inc. is a global biopharmaceutical company that was formed in 2013 after separating from Abbott Laboratories. The company develops innovative medicines for complex health issues across immunology, oncology, neuroscience, and aesthetics. AbbVie operates in over 70 countries worldwide.
The company's flagship product is Humira, monoclonal antibody used to treat autoimmune diseases like rheumatoid arthritis and Crohn's disease. Other major products include Skyrizi for for treating plaque psoriasis, Botox for aesthetics, and Imbruvica for cancer treatment.
The company was established in 2013, and is headquartered in North Chicago, Illinois.
AbbVie Inc. (ABBV) Historical Performance
IPO Date
AbbVie Inc. (NYSE:ABBV) went public on 02 January, 2013.
Change
Since inception, ABBV has increased by 841.48%. In the last 5 years, ABBV has risen from $66.60 to $210.75, a massive 216.43% increase since 2020.
Historical Highs and Lows
In the past 5 years, the stock reached a high of $210.75 and a low of $66.60.
52 Week Range
$153.58
$215.66
The current price $210.75 is near the 52-week high, which means that the stock is overbought.
ABBV Stock Price History
Based on ABBV stock's historical price data, this table shows how the stock has performed in the last 6 years. Since 2019, the ABBV stock has risen from $61.73 - $90.4 to $182.18 - $210.75, which is up 232.23%. Currently, the stock follows upward trend.
Here, we have calculated stock range of ABBV, indicating the highs and lows for each year, the average price based on the daily closing prices each year, and the change% from the average price.
| Year | Stock Price | Avg Price | Change% | Year Change |
|---|---|---|---|---|
| 2020 | $61.73 - $90.4 | $74.97 | 24.13 | 1 Year Change |
| 2021 | $86.46 - $119.72 | $98.59 | 63.24 | 2 Year Change |
| 2022 | $121.03 - $148.46 | $133.59 | 121.2 | 3 Year Change |
| 2023 | $126.09 - $148.11 | $138.29 | 128.98 | 4 Year Change |
| 2024 | $156.92 - $200.37 | $175.73 | 190.97 | 5 Year Change |
| 2025 | $182.18 - $210.75 | $200.65 | 232.23 | 6 Year Change |
ABBV Price Performance
6-Month Performance
ABBV stock jumped by 5.18% in the last six months.
1-Year Performance
The stock has trended upwards by 34.30% in the past year.
3-Year Performance
In the last 3 years, the stock has soared by 60.62%.
5-Year Performance
In the last 5 years, the stock has gone up by 216.43%.
According to AbbVie Inc.'s historical data, below graph gives us the exact picture of how the ABBV stock has performed year-over-year. Here, Each bar on the graph represents a particular year that illustrates how the stock's price changed from one year to the next.
YoY Performance
In the last five years, the stock has shown positive growth in 4 years and a decline in 1 year.
2020
27.72% ↑
2021
32.43% ↑
2022
24.01% ↑
2023
0.23% ↓
2024
18.86% ↑
NOTE: Green bars indicate that the stock has risen compared to the previous year, while red bars show that the stock has fallen.
AbbVie Inc. (ABBV) Financials & Stock Analysis
Total Revenue
Quarterly Revenue: $15.10 B (Q4)
Revenue for Q4 ending 31st December, 2024 increased 4.44% compared to Q3 ending 30th September, 2024.
Annual Revenue: $56.33 B (1Y)
Revenue for trailing 12 months decreased 0.00% year over year from 31st December, 2024.
If compared to the last 4 years, the revenue has gone up from $56.20 billion to $56.33 billion, a 0.24% change.
Market Capitalization
AbbVie Inc. has a market capitalization of $372.05B, which places ABBV in the mega-cap category.
Fundamental Analysis
EPS: $-0.01 (Q4), $2.42 (1Y)
EPS decreased 101.41% since last quarter, and decreased 11.23% since last year.
Net Income: $-22.00 M (Q4), $4.28 B (1Y)
Net Income decreased 101.41% since last quarter, and decreased 12.03% since last year.
Free Cash Flow: $6.76 B (Q4), $17.83 B (1Y)
Free Cash Flow increased 29.99% since last quarter, and decreased 19.17% since last year.
Net Profit Margin: -0.15% (Q4), 7.59% (1Y)
Net Profit Margin decreased 101.35% since last quarter, and decreased 12.03% since last year.
Below, we have listed 12 key indicators for Fundamental analysis for ABBV stock. These indicators help you understand AbbVie Inc.'s financial health, earnings and growth potential, and make a decision if the stock is a good long-term investment or not.
|
|
Technical Analysis
Here, we have listed 5 key indicators for Technical Analysis for ABBV stock. These indicators help investors study past price movements and trading volumes to forecast future price changes, and find the right time when to buy, sell or hold the stock.
| Technical Indicators | Value |
|---|---|
| SMA20 | $200.42 |
| SMA50 | $186.25 |
| SMA200 | $180.61 |
| RSI | 79.09 |
| Beta | 0.60 |
SMA20 < Current Price
This signals ABBV stock is in short-term bullish momentum.
SMA50 < Current Price
This signals ABBV stock is in mid-term bullish momentum.
SMA200 < Current Price
This signals ABBV stock is in long-term bullish momentum.
Sentiment Based on Technical Analysis
Based on 8 technical analysis indicators, the overall sentiment for ABBV stock is Bullish. Out of all indicators, 5 indicates bullish signals, 3 signals bearish trends and 1 gives neutral trends. The ABBV stock forecast was last updated on 07 March, 2025.
AbbVie Inc. (ABBV) Stock Price Prediction and Forecast
According to short-term forecast, the stock is expected to rise to $429.54 by the end of 2025, and can reach around $431.93 to $458.91 in 2026. And, the long-term forecast suggests that the stock may further jump to $602.68 - $637.26 in 2028, and $737.91 - $891.25 by 2031. So, the ABBV stock shows a strong upward trend in the next several years.
Short-term ABBV Stock Price Prediction & Forecast
| Date | Forecasted Price | Change% |
|---|---|---|
| 2025-04 | $363.75 | 72.6% |
| 2025-05 | $367.09 | 74.18% |
| 2025-06 | $382.07 | 81.29% |
| 2025-07 | $401.01 | 90.28% |
| 2025-08 | $417.97 | 98.33% |
| 2025-09 | $422.73 | 100.58% |
| 2025-10 | $405.94 | 92.62% |
| 2025-11 | $413.27 | 96.09% |
| 2025-12 | $429.54 | 103.81% |
In 2025, the ABBV stock price is expected to fluctuate between $363.75 and $429.54. According to the monthly forecast, the stock could rise to $429.54 by December 2024. If compared to the ABBV's current price, the stock could gain 103.81% by the end of this year.
Long-term ABBV Stock Price Prediction & Forecast
| Year | Year Start | Year Mid | Year End | Change% |
|---|---|---|---|---|
| 2026 | $431.93 | $438.42 | $458.91 | 117.75% |
| 2027 | $533.63 | $547.59 | $529.53 | 151.26% |
| 2028 | $602.68 | $624.43 | $637.26 | 202.38% |
| 2029 | $633.14 | $672.44 | $741.55 | 251.86% |
| 2030 | $689.84 | $859.84 | $800.78 | 279.97% |
| 2031 | $737.91 | $818.82 | $891.25 | 322.89% |
| 2032 | $980.02 | $943.48 | $1035.02 | 391.11% |
| 2033 | $1079.16 | $1108.26 | $1044.98 | 395.84% |
| 2034 | $1041.61 | $1049.30 | $1144.32 | 442.98% |
| 2035 | $1289.11 | $1144.81 | $1281.15 | 507.9% |
| 2036 | $1305.02 | $1231.04 | $1343.75 | 537.6% |
| 2037 | $1471.39 | $1495.01 | $1335.68 | 533.77% |
| 2038 | $1469.28 | $1634.67 | $1374.80 | 552.34% |
| 2039 | $1566.28 | $1644.38 | $1578.63 | 649.05% |
| 2040 | $1596.38 | $1704.78 | $1696.67 | 705.06% |
| 2041 | $1736.94 | $1596.00 | $1861.37 | 783.21% |
| 2042 | $1692.44 | $1633.20 | $1689.30 | 701.57% |
| 2043 | $1933.03 | $1949.97 | $1979.44 | 839.24% |
| 2044 | $1858.26 | $1901.57 | $2015.89 | 856.53% |
| 2045 | $1898.29 | $2032.76 | $2463.10 | 1068.73% |
| 2046 | $2051.94 | $2032.18 | $2236.24 | 961.09% |
| 2047 | $2410.10 | $2253.96 | $1965.61 | 832.67% |
| 2048 | $2024.10 | $2280.61 | $2019.71 | 858.34% |
| 2049 | $2625.54 | $2088.79 | $2566.09 | 1117.6% |
| 2050 | $2725.44 | $2374.48 | $2462.79 | 1068.58% |
| 2051 | $2348.41 | $2753.93 | $2609.80 | 1138.34% |
AbbVie Inc. (ABBV) Stock Price Prediction & Forecast 2025
At the start of 2025, the ABBV stock was at $182.18. Today, it is trading at $210.75, which is 15.68% increase from price at the beginning of the year. By the end of this year, you can expect the stock to reach to $429.54 by December 2025 with a 103.81% change.
AbbVie Inc. (ABBV) Stock Price Prediction & Forecast 2026 - 2030
In the next five years, there will be a significant appreciation in the ABBV stock. During this period, the ABBV's price is forecasted to shift from $431.93 to $800.78, which is 85.40% gain.
In 2026, the stock would possibly open at $431.93, escalates to $438.42 by mid-year, and wraps up at $458.91, reflecting a 117.75% increase from today's price. Further moving to 2030, the stock can kick off the year at $689.84, soar to $859.84 by mid-year, and finish at $800.78, which is 279.97% change from current price.
AbbVie Inc. (ABBV) Stock Price Prediction & Forecast 2031 - 2040
During this period, the stock would move from $737.91 to $1696.67, which is up 322.89%
In 2031, we can expect ABBV to fluctuate between $737.91 and $891.25, a shift indicating a 322.89% gain by year-end compared to current price. And Until 2040, ABBV can likely vary from $1596.38 to $1696.67. By the end of 2040, the stock could record a 705.06% rise from today's stock price.
AbbVie Inc. (ABBV) Stock Price Prediction & Forecast 2041 - 2050
According to long-term forecast, the ABBV stock can see an an upturn from $1736.94 to $2462.79 in this period. In 2041, the stock can experience a low of $1596.00 by mid-year, closing the year at $1861.37. This results in a 657.29% increase from today.
Moving towards the end of 2050, ABBV is projected to open the year at $2725.44. The stock may dip to $2374.48 during mid-year and finish the year at $2462.79. Compared to the stock's current price, this translates to an overall gain of 1068.58% by 2050.
Become a member
Get the latest news right in your inbox. We never spam!
ABBV Competitors
| Ticker | Company | Market Cap | Price | 1m Change | Forecast |
|---|---|---|---|---|---|
| NVO | Novo Nordisk A/S | - | $83.91 | -0.64% ▼ | $205.93 ▲ |
| LLY | Eli Lilly and Company | - | $844.27 | 4.09% ▲ | $112.92 ▲ |
| JNJ | Johnson & Johnson | - | $153.12 | 0.64% ▲ | $92.65 ▲ |
| PFE | Pfizer Inc. | - | $25.74 | -1.34% ▼ | $105.29 ▲ |
Last updated Mar 07 at 3:07 PM
ABBV : Buy, Sell Or Hold?
Analyst Ratings
Based on 26 analysts, 5 rated as a strong buy, 11 recommended a buy, 10 suggested a hold, 0 advised a sell, and 0 indicated a strong sell.Three months ago, out of 27 analysts, 6 analysts gave a strong buy rating, 12 a buy rating, 9 a hold rating, 0 advised selling, and 0 suggested a strong sell.So, according to analyst ratings, the recommendation for ABBV stock is Buy.
Expert Analysis
According to ABBV short-term and long-term forecast, AbbVie Inc. shares are projected to go up by 1068.58%, and reach a value of $2462.79 per share by 2050.
As per technical analysis, indicators show a Bullish sentiment, while Fear & Greed Index stands at 85.71428571428571, which signals Greed. Also, ABBV has recorded 14/30 green days, which reflects a 63.63636363636363% positivity rate with a price volatility of 0.01%.
Plus, Price-to-Earnings (P/E) ratio of 88.550415 suggests that ABBV stock is overvalued. So, Based on ABBV prediction and analysis, it may be the best time to hold ABBV stock right now.
Disclaimer: Stock predictions, forecasts and price targets provided for "ABBV” are solely for informational and educational purposes and should not be treated as investment or financial advice. Always conduct your own research or consider consulting with a financial advisor before making any investment decisions.